Home Cart Sign in  
Chemical Structure| 14123-76-3 Chemical Structure| 14123-76-3
Chemical Structure| 14123-76-3

*Storage: Sealed in dry,2-8°C.

*Shipping: Normal

6-Chloro-3-methylisoquinoline

CAS No.: 14123-76-3

4.5 *For Research Use Only !

Cat. No.: A162142 Purity: 97%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
100mg łËò¶ÊÊ Inquiry Inquiry Login
250mg ł§Ë¶ÊÊ In Stock In Stock Login
1g łď˶ÊÊ In Stock In Stock Login
5g ł§ÿò¶ÊÊ In Stock In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 100mg

    łËò¶ÊÊ

  • 250mg

    ł§Ë¶ÊÊ

  • 1g

    łď˶ÊÊ

  • 5g

    ł§ÿò¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 14123-76-3 ]

CAS No. :14123-76-3
Formula : C10H8ClN
M.W : 177.63
SMILES Code : CC1=CC2=C(C=CC(Cl)=C2)C=N1
MDL No. :MFCD11110658
Boiling Point : No data available
InChI Key :VLPNHJHAQSABQP-UHFFFAOYSA-N
Pubchem ID :20616787

Safety of [ 14123-76-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 14123-76-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 10
Fraction Csp3 0.1
Num. rotatable bonds 0
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 51.72
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

12.89 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.24
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.31
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.2
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.44
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

3.56
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.95

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.64
Solubility 0.0404 mg/ml ; 0.000227 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.26
Solubility 0.0984 mg/ml ; 0.000554 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.7
Solubility 0.00354 mg/ml ; 0.0000199 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.03 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.24

Application In Synthesis [ 14123-76-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 14123-76-3 ]

[ 14123-76-3 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 919994-55-1 ]
  • [ 14123-76-3 ]
YieldReaction ConditionsOperation in experiment
76% at 130 - 140℃; for 3.16667 h; During 10 min. (4-chloro-benzyl)-[2,2-dimethoxy-1-methyl-eth-(Z)-ylidene]-amine (120 g, 0.496 mol) was added dropwise to polyphosphoric acid (1000 g) at 130 0C. The resulting reaction mixture was heated for 3 h at 140 0C. After cooling below 100 0C the reaction mixture was poured onto ice (1 kg) and neutralized (pH = 7) with a 33 percent aqueous NaOH solution. Care was taken that the temperature did not rise above 35 0C by adding additional ice. The reaction mixture was extracted with dichloromethane (3 x 1 L) and the combined organic layers were dried over Na2SO4, filtered and concentrated at reduced pressure to afford a black oil. The crude product was purified bulb-to-bulb distillation (105 -110 0C, 2 mbar) to afford the title compound as colorless oil which crystallized upon standing (66.7 g, 0.375 mol, 76percent). MS (ES+): 178 (M(C10H835CIN)+H)+.
References: [1] Patent: WO2007/6533, 2007, A2, . Location in patent: Page/Page column 32.
  • 2
  • [ 108-22-5 ]
  • [ 80055-48-7 ]
  • [ 14123-76-3 ]
References: [1] Chemical Communications, 2015, vol. 51, # 68, p. 13327 - 13329.
  • 3
  • [ 104-86-9 ]
  • [ 14123-76-3 ]
References: [1] Patent: WO2016/83816, 2016, A1, .
  • 4
  • [ 6342-56-9 ]
  • [ 104-86-9 ]
  • [ 14123-76-3 ]
References: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 17, p. 7412 - 7424.
 

Related Products

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 14123-76-3 ]

Chlorides

Chemical Structure| 34784-06-0

A204259 [34784-06-0]

7-Chloroisoquinoline

Similarity: 0.88

Chemical Structure| 62882-02-4

A224530 [62882-02-4]

6-Chloroisoquinoline

Similarity: 0.88

Chemical Structure| 147937-36-8

A320617 [147937-36-8]

3-(Chloromethyl)isoquinoline

Similarity: 0.83

Chemical Structure| 612-61-3

A105655 [612-61-3]

7-Chloroquinoline

Similarity: 0.82

Chemical Structure| 5430-45-5

A493591 [5430-45-5]

5-Chloroisoquinoline

Similarity: 0.80

Related Parent Nucleus of
[ 14123-76-3 ]

Isoquinolines

Chemical Structure| 34784-06-0

A204259 [34784-06-0]

7-Chloroisoquinoline

Similarity: 0.88

Chemical Structure| 62882-02-4

A224530 [62882-02-4]

6-Chloroisoquinoline

Similarity: 0.88

Chemical Structure| 147937-36-8

A320617 [147937-36-8]

3-(Chloromethyl)isoquinoline

Similarity: 0.83

Chemical Structure| 34784-07-1

A144432 [34784-07-1]

8-Chloroisoquinoline

Similarity: 0.80

Chemical Structure| 5430-45-5

A493591 [5430-45-5]

5-Chloroisoquinoline

Similarity: 0.80